ID   UACC-91
AC   CVCL_M447
SY   UACC 91; UACC91; UACC-091; UACC 091; UACC091; University of Arizona Cell Culture-91
DR   BTO; BTO:0005899
DR   Wikidata; Q54973869
RX   PubMed=2300817;
RX   PubMed=10952317;
RX   PubMed=23039341;
RX   PubMed=24879157;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
RX   PubMed=2300817; DOI=10.1126/science.2300817;
RA   Trent J.M., Stanbridge E.J., McBride H.L., Meese E.U., Casey G.,
RA   Araujo D.E., Witkowski C.M., Nagle R.B.;
RT   "Tumorigenicity in human melanoma cell lines controlled by
RT   introduction of human chromosome 6.";
RL   Science 247:568-571(1990).
//
RX   PubMed=10952317; DOI=10.1038/35020115;
RA   Bittner M., Meltzer P.S., Chen Y.-D., Jiang Y., Seftor E.A.,
RA   Hendrix M.J.C., Radmacher M.D., Simon R.M., Yakhini Z., Ben-Dor A.,
RA   Sampas N., Dougherty E., Wang E., Marincola F.M., Gooden C., Lueders J.,
RA   Glatfelter A., Pollock P.M., Carpten J.D., Gillanders E.M., Leja D.,
RA   Dietrich K., Beaudry C., Berens M.E., Alberts D.S., Sondak V.K.,
RA   Hayward N.K., Trent J.M.;
RT   "Molecular classification of cutaneous malignant melanoma by gene
RT   expression profiling.";
RL   Nature 406:536-540(2000).
//
RX   PubMed=23039341; DOI=10.1186/1476-4598-11-75;
RA   Byron S.A., Loch D.C., Wellens C.L., Wortmann A., Wu J.-Y., Wang J.,
RA   Nomoto K., Pollock P.M.;
RT   "Sensitivity to the MEK inhibitor E6201 in melanoma cells is
RT   associated with mutant BRAF and wildtype PTEN status.";
RL   Mol. Cancer 11:75.1-75.15(2012).
//
RX   PubMed=24879157; DOI=10.4161/auto.28594;
RA   Goodall M.L., Wang T., Martin K.R., Kortus M.G., Kauffman A.L.,
RA   Trent J.M., Gately S., MacKeigan J.P.;
RT   "Development of potent autophagy inhibitors that sensitize oncogenic
RT   BRAF V600E mutant melanoma tumor cells to vemurafenib.";
RL   Autophagy 10:1120-1136(2014).
//